Jefferies Group LLC Alkermes Plc. Call Options Transaction History

Jefferies Group LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $356,400 - $516,294	16,200 New	16,200 $362,000
Q4 2019 Feb 13, 2020	BUY	$17.29 - $21.74 $1.41 Million - $1.78 Million	81,700 New	81,700 $1.67 Million
Q1 2019 May 15, 2019	SELL	$28.4 - $36.49 $2.01 Million - $2.58 Million	-70,800 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$27.94 - $44.61 $1.98 Million - $3.16 Million	70,800 New	70,800 $2.09 Million

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.87B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.